Trial · NCT02233023
Registered outcomes12
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
1 to 12 of 12
Download this page as JSON| List | Outcome | Time frame | Description |
|---|---|---|---|
| Primary | Incidence of drug related signs of retinal degeneration | up to 8 months | based on the evaluation of assessors blind to the treatment allocation |
| Secondary | Assessment of ophthalmological history | within 2 month after neurologic visit | |
| Secondary | Assessment of visual acuity | within 2 month after neurologic visit | |
| Secondary | Number of abnormal findings in clinical examination in miosis and mydriasis | within 2 month after neurologic visit | including ophthalmoscopy |
| Secondary | Assessment of intraocular pressure (mmHg) | within 2 month after neurologic visit | |
| Secondary | Assessment of colour vision | within 2 month after neurologic visit | using the Hardy-Rand-Rittler (H-R-R) pseudoisochromatic plates |
| Secondary | Findings in kinetic perimetry | within 2 month after neurologic visit | |
| Secondary | Percentage of patients with elevated dark adaptation thresholds | within 2 month after neurologic visit | |
| Secondary | Assessment of Parkinson's Disease stage rated by modified Hoehn and Yahr Scale | within less than 2 months before ophthalmologic visit | |
| Secondary | Assessment of Parkinson's Disease stage rated of unified Parkinson's Disease Rating Scale (UPDRS) Part IV | within less than 2 months before ophthalmologic visit | |
| Secondary | Number of patients with adverse events | up to 2 month after neurologic visit | |
| Secondary | Findings in standardised electroretinography (ERG) | within 2 monhts after neurologic visit | performed according to International Standardization Committee for the Electrophysiology of Vision (ISCEV) standard |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT02233023/registered